Skip to Main Content

Author Details

Sarah Wordsworth
Health Economics Research Centre, University of Oxford
1997
134
33
PMIDPaper TitleJournal TitlePublished Year
36229359Cost-Effectiveness Analysis of Treating Patients With NTRK-Positive Cancer With the Histology-Independent Therapy Entrectinib.Value Health2023
37623911Financial incentives to promote personalized medicine in Europe: an overview and guidance for implementation.Per Med2023
37658729Long-term cost-effectiveness of a melanoma prevention program using genomic risk information compared with standard prevention advice in Australia.Genet Med2023
37577962Budget impact and transferability of cost-effectiveness of <i>DPYD</i> testing in metastatic breast cancer in three health systems.Per Med2023
37435838Bleeding risk in patients prescribed dual antiplatelet therapy and triple therapy after coronary interventions: the ADAPTT retrospective population-based cohort studies.Health Technol Assess2023
34175442Clinical utility of whole-genome sequencing in precision oncology.Semin Cancer Biol2022
35473510Can upfront DPYD extended variant testing reduce toxicity and associated hospital costs of fluoropyrimidine chemotherapy? A propensity score matched analysis of 2022 UK patients.BMC Cancer2022
35575786Can polygenic risk scores contribute to cost-effective cancer screening? A systematic review.Genet Med2022
35368231Financing and Reimbursement Models for Personalised Medicine: A Systematic Review to Identify Current Models and Future Options.Appl Health Econ Health Policy2022
35426781Supraglottic airway device versus tracheal intubation in the initial airway management of out-of-hospital cardiac arrest: the AIRWAYS-2 cluster RCT.Health Technol Assess2022
36524582Impact of video-assisted thoracoscopic lobectomy versus open lobectomy for lung cancer on recovery assessed using self-reported physical function: VIOLET RCT.Health Technol Assess2022
36351667Integrating genome-wide polygenic risk scores and non-genetic risk to predict colorectal cancer diagnosis using UK Biobank data: population based cohort study.BMJ2022
36152236Resource allocation in genetic and genomic medicine.J Community Genet2022
35248467The Net Benefit of Personalized Medicine: A Systematic Literature Review and Regression Analysis.Value Health2022
35216902Defining a Core Data Set for the Economic Evaluation of Precision Oncology.Value Health2022
35194876Eliciting risk preferences that predict risky health behavior: A comparison of two approaches.Health Econ2022
34787942Utility maximization versus regret minimization in health choice behavior: Evidence from four datasets.Health Econ2022
34145384Correction to: Toward the diagnosis of rare childhood genetic diseases: what do parents value most?Eur J Hum Genet2021
33771192Is there a renoprotective value to leukodepletion during heart valve surgery? A randomized controlled trial (ROLO).J Cardiothorac Surg2021
33574068Availability and funding of clinical genomic sequencing globally.BMJ Glob Health2021
33682065Preferences for Medical Consultations from Online Providers: Evidence from a Discrete Choice Experiment in the United Kingdom.Appl Health Econ Health Policy2021
33903739Toward the diagnosis of rare childhood genetic diseases: what do parents value most?Eur J Hum Genet2021
33840432Content of Health Economics Analysis Plans (HEAPs) for Trial-Based Economic Evaluations: Expert Delphi Consensus Survey.Value Health2021
33860928Guidance for the Harmonisation and Improvement of Economic Evaluations of Personalised Medicine.Pharmacoeconomics2021
34409564What Aspects of Illness Influence Public Preferences for Healthcare Priority Setting? A Discrete Choice Experiment in the UK.Pharmacoeconomics2021
34758253100,000 Genomes Pilot on Rare-Disease Diagnosis in Health Care - Preliminary Report.N Engl J Med2021
34460825Public preferences for delayed or immediate antibiotic prescriptions in UK primary care: A choice experiment.PLoS Med2021
34385669Impact of personal genomic risk information on melanoma prevention behaviors and psychological outcomes: a randomized controlled trial.Genet Med2021
34126133Cost-effectiveness of the i-gel supraglottic airway device compared to tracheal intubation during out-of-hospital cardiac arrest: Findings from the AIRWAYS-2 randomised controlled trial.Resuscitation2021
34211116Does bariatric surgery reduce future hospital costs? A propensity score-matched analysis using UK Biobank Study data.Int J Obes (Lond)2021
31358947The complete costs of genome sequencing: a microcosting study in cancer and rare diseases from a single center in the United Kingdom.Genet Med2020
31741314A Review of Health Economic Studies Comparing Traditional and Massively Parallel Sequencing Diagnostic Pathways for Suspected Genetic Disorders.Pharmacoeconomics2020
33444208Effectiveness, cost-effectiveness and safety of gabapentin versus placebo as an adjunct to multimodal pain regimens in surgical patients: protocol of a placebo controlled randomised controlled trial with blinding (GAP study).BMJ Open2020
33066092Awareness of Appropriate Antibiotic Use in Primary Care for Influenza-Like Illness: Evidence of Improvement from UK Population-Based Surveys.Antibiotics (Basel)2020
32727604Why do hospital prescribers continue antibiotics when it is safe to stop? Results of a choice experiment survey.BMC Med2020
33010371Randomized trial of the i-gel supraglottic airway device versus tracheal intubation during out of hospital cardiac arrest (AIRWAYS-2): Patient outcomes at three and six months.Resuscitation2020
32389221Addressing Challenges of Economic Evaluation in Precision Medicine Using Dynamic Simulation Modeling.Value Health2020
32321478Reducing expectations for antibiotics in primary care: a randomised experiment to test the response to fear-based messages about antimicrobial resistance.BMC Med2020
30284701Evaluating the Outcomes Associated with Genomic Sequencing: A Roadmap for Future Research.Pharmacoecon Open2019
31615795Study protocol for VIdeo assisted thoracoscopic lobectomy versus conventional Open LobEcTomy for lung cancer, a UK multicentre randomised controlled trial with an internal pilot (the VIOLET study).BMJ Open2019
31186546Do health professionals value genomic testing? A discrete choice experiment in inherited cardiovascular disease.Eur J Hum Genet2019
31300495Cardiovascular magnetic resonance in emergency patients with multivessel disease or unobstructed coronary arteries: a cost-effectiveness analysis in the UK.BMJ Open2019
31345272Implementation of a genomic medicine multi-disciplinary team approach for rare disease in the clinical setting: a prospective exome sequencing case series.Genome Med2019
31221165Optimising trial designs to identify appropriate antibiotic treatment durations.BMC Med2019
30948524The challenge of antimicrobial resistance: What economics can contribute.Science2019
30922313Correction to: Will the reformed Cancer Drugs Fund address the most common types of uncertainty? An analysis of NICE cancer drug appraisals.BMC Health Serv Res2019
31167875Comprehensive ascertainment of bleeding in patients prescribed different combinations of dual antiplatelet therapy (DAPT) and triple therapy (TT) in the UK: study protocol for three population-based cohort studies emulating 'target trials' (the ADAPTT Study).BMJ Open2019
30941659A Review of the Challenges of Using Biomedical Big Data for Economic Evaluations of Precision Medicine.Appl Health Econ Health Policy2019
31102918Risk attitudes and sun protection behaviour: Can behaviour be altered by using a melanoma genomic risk intervention?Cancer Epidemiol2019
30368646Multi-Centre Micro-Costing of Roux-En-Y Gastric Bypass, Sleeve Gastrectomy and Adjustable Gastric Banding Procedures for the Treatment of Severe, Complex Obesity.Obes Surg2019
  • 1 - 50 of 134

Recommended Authors

Nathaniel Hendrix
Harvard T.H. Chan School of Public Health
Career Start Year 2017
Number of shared co-authors 0
Thomas Butt
UCL Institute of Ophthalmology, University College London
Career Start Year 2013
Number of shared co-authors 2
Jeff Round
Institute of Health Economics, University of Alberta
Career Start Year 2010
Number of shared co-authors 2
Dalia Dawoud
Stanford University
Career Start Year 2010
Number of shared co-authors 2
Mike Paulden
School of Public Health, University of Alberta
Career Start Year 2009
Number of shared co-authors 1
Benjamin P Geisler
Massachusetts General Hospital, Harvard Medical School
Career Start Year 2008
Number of shared co-authors 0
Christine Y Lu
Harvard Medical School and the Harvard Pilgrim Health Care Institute
Career Start Year 2004
Number of shared co-authors 1
Nicholas Mitsakakis
Institute of Health Policy Management and Evaluation, University of Toronto
Career Start Year 2003
Number of shared co-authors 0
Craig R Ramsay
Health Services Research Unit, University of Aberdeen
Career Start Year 1998
Number of shared co-authors 5
Victor M Montori
Knowledge and Evaluation Research Unit in Endocrinology (KER_Endo), Mayo Clinic
Career Start Year 1998
Number of shared co-authors 0
Emily Beth Devine
University of Washington
Career Start Year 1997
Number of shared co-authors 0
Andrew Walker
University of California San Diego
Career Start Year 1995
Number of shared co-authors 0
Mireille Goetghebeur
School of Public Health, Universite de Montreal 1
Career Start Year 1995
Number of shared co-authors 0
George Tomlinson
University Health Network
Career Start Year 1994
Number of shared co-authors 0
David O Meltzer
The University of Chicago
Career Start Year 1993
Number of shared co-authors 0
Ben van Hout
University of Sheffield
Career Start Year 1993
Number of shared co-authors 0
Jason N Doctor
University of Southern California
Career Start Year 1992
Number of shared co-authors 0
David L Veenstra
University of Washington
Career Start Year 1992
Number of shared co-authors 3
Jonathan J Deeks
Institute of Applied Health Research, University of Birmingham
Career Start Year 1991
Number of shared co-authors 2
Chris L Pashos
Data Sciences Institute, Takeda Pharmaceuticals International Inc.
Career Start Year 1990
Number of shared co-authors 0
Patrick M M Bossuyt
University of Amsterdam
Career Start Year 1989
Number of shared co-authors 1
David A Asch
University of Pennsylvania, USA Leonard Davis Institute of Health Economics
Career Start Year 1988
Number of shared co-authors 0
Mark S Roberts
School of Public Health, University of Pittsburgh
Career Start Year 1988
Number of shared co-authors 0
Sean Tunis
Center for Evaluation of Value and Risk in Health, Tufts Medical Center
Career Start Year 1987
Number of shared co-authors 1
John B Wong
Tufts University School of Medicine
Career Start Year 1986
Number of shared co-authors 0
Benjamin Djulbegovic
Medical University of South Carolina
Career Start Year 1985
Number of shared co-authors 0
Wendy J Ungar
The Hospital for Sick Children
Career Start Year 1984
Number of shared co-authors 2
Mark Helfand
Oregon Health & Science University
Career Start Year 1983
Number of shared co-authors 0
Theodore G Ganiats
university of california san diego
Career Start Year 1983
Number of shared co-authors 0
Stan N Finkelstein
University of Toronto
Career Start Year 1977
Number of shared co-authors 0

Collaborators

James Buchanan
Health Economics Research Centre, University of Oxford
Co-authored papers 35
Jenny C Taylor
University of Oxford
Co-authored papers 13
Usha Chakravarthy
Queen's University Belfast
Co-authored papers 8
Andrew D Mumford
University of Bristol
Co-authored papers 5
Tunde Peto
Queen's University Belfast
Co-authored papers 5
Ruth E Hogg
Queen's University Belfast
Co-authored papers 4
Brenda J Wilson
Memorial University
Co-authored papers 4
Christopher C Butler
University of Oxford
Co-authored papers 4
Andrew J Lotery
University of Southampton
Co-authored papers 3
John Taylor
Oxford University Hospitals NHS Foundation Trust, Churchill Hospital
Co-authored papers 3
Carme Camps
National Institute for Health Research Biomedical Research Centre
Co-authored papers 3
Hugh Watkins
Co-authored papers 3
Andrea H N??meth
University of Oxford
Co-authored papers 2
Andrew O M Wilkie
NIHR Oxford Biomedical Research Centre
Co-authored papers 2
Ainsley J Newson
Sydney Health Ethics, Sydney School of Public Health, The University of Sydney
Co-authored papers 2
Judy Kirk
Co-authored papers 2
Hugh Dawkins
The University of Notre Dame Australia
Co-authored papers 2
Christopher McCabe
Queens University Belfast
Co-authored papers 2
Jim Davies
NIHR Oxford Biomedical Research Centre
Co-authored papers 2
Alistair T Pagnamenta
NIHR Biomedical Research Centre, University of Oxford
Co-authored papers 2
Jonathan A C Sterne
University of Bristol
Co-authored papers 2
E V Davison
University of Newcastle upon Tyne.
Co-authored papers 2
Tracy Lester
Oxford University Hospitals NHS Foundation Trust, Churchill Hospital
Co-authored papers 2
Carlos Caldas
Cancer Research UK Cambridge Institute, University of Cambridge
Co-authored papers 1
Valentina Cipriani
William Harvey Research Institute, Queen Mary University of London
Co-authored papers 1
Christopher Boustred
Co-authored papers 1
Anna de Burca
Oxford University Hospitals NHS Foundation Trust
Co-authored papers 1
Charu Deshpande
Guy's Hospital
Co-authored papers 1
Bishoy Habib
Co-authored papers 1
Gr??inne S Gorman
Newcastle upon Tyne Hospitals NHS Foundation Trust
Co-authored papers 1
Release 1.2